— Український інформаційний портал урологів
(Украинский информационный портал урологов)

О проекте
О нас
Конференции и симпозиумы
Реформы и предложения
Нормативные документы
Наши партнеры

Информация для пациентов

Консультации уролога

Ассоциация урологов Украины
Сайт Института урологии Академии медицинских наук Украины
Европейская Ассоциация Урологов - Урологический информационный портал — исследователь урологии
Удовлетворительная ли у Вас зарпата? Какую Вы бы хотели иметь зарлату?
Как Вы оцениваете уровень медицины в Украине (10 баллов максимум)

Review of ESMO Annual Congress 2016 Версия для печати Отправить на e-mail

Welcome to the latest edition of EMJ Oncology, providing a selection of articles regarding research from the expansive field of oncology as well as news from the European Society for Medical Oncology (ESMO) Congress.  For those who were unable to attend the biggest oncological event of the year, we have all the latest updates right here, from the magnificent Nordic city of Copenhagen, Denmark. We have included a wide array of abstracts showcased at this year’s spectacle as well as the latest updates from the wider oncological world. This year’s event spanned an impressive 5 days, welcoming many participants from all over the world. The congress review this year is not to be missed, covering a range of topics including clinical trials and further considerations of cancer treatment, and the financial burden such an illness has for patients. We also include two fascinating feature articles based on interviews that were undertaken with two prominent researchers at the ESMO Congress regarding the studies they presented at the event.



This year our Editor’s Pick comes from Nielsen et al. who explore muscle dysfunction in childhood cancer. According to Nielsen and colleagues, emerging evidence implies that muscle toxicities related to treatment could go on to produce long-term consequences. This captivating article suggests that skeletal muscle toxicities could indeed be an integral part of the development of late adverse effects in childhood cancer survivors. Delving deeper into our eJournal, Lipski et al.deliberate the safety and efficacy of endoscopic surgery. Within their article, the authors discuss the importance of further studies concerning new technology. Adil et al. provide a review on gastrointestinal stromal tumours, commonly known to occur in all parts of the gastrointestinal tract in older patients. Kaggwa et al. discuss bladder outlet obstruction in men with prostate cancer in a Sub-Saharan environment. This retrospective study was conducted in a hospital in Kampala, Uganda, which set out to investigate the efficacy of certain therapies to relieve the symptoms. Blau et al. provide an overview of somatic mutations in myelodysplastic syndrome patients, and additionally, Jung et al. examine microRNAs that confer resistance to different treatments in breast cancer.


What's included in this edition of EMJ Oncology?

Editorial Board

Congress Review
Review of the European Society of Medical Oncology (ESMO) Congress, held in Copenhagen, Denmark, 7th–11th October 2016




Symposium Reviews

Abstract Reviews



Buyer’s Guide

Get Involved

Here at the European Medical Journal we are confident that you will find this year’s edition of EMJ Oncology a captivating read, and hope that you will find it useful to your daily practice going forward. Ensure you make time to subscribe to the EMJ, for the next edition of our flagship eJournal, European Medical Journal 1.4, which will be published in mid-December. Additionally, do not forget to browse EMJ 1.3, published earlier this year, encompassing a broad spectrum of therapeutic areas. To keep on top of our day-to-day progress and receive regular news and events updates, please connect with us on FacebookTwitter, and LinkedIn.

Последнее обновление ( 13.12.2016 )  
< Пред.   След. >
Назад - Український інформаційний портал урологів (Украинский информационный портал урологов) © 2021